Agrani Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 01-06-2024
- Paid Up Capital ₹ 0.50 M
as on 01-06-2024
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2018
- Open Charges ₹ 0.50 M
as on 01-06-2024
About Agrani Pharmaceutical
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹0.50 M.
Alok Kumar, Rana Singh, Padum Singh, and One other member serve as directors at the Company.
- CIN/LLPIN
U24233HR2016PTC058475
- Company No.
058475
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Mar 2016
- Date of AGM
27 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Panchkula, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Agrani Pharmaceutical?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alok Kumar  | Director | 04-Mar-2016 | Current |
| Rana Singh | Director | 04-Mar-2016 | Current |
| Padum Singh | Director | 04-Mar-2016 | Current |
| Vijaya Laxmi | Director | 04-Mar-2016 | Current |
Financial Performance of Agrani Pharmaceutical.
Enhance accessibility to Agrani Pharmaceutical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Agrani Pharmaceutical?
Unlock access to Agrani Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Agrani Homes Private LimitedActive 13 years 9 monthsAlok Kumar, Rana Singh and 1 more are mutual person
- Agrani Homes Real Construction Private LimitedActive 11 years 1 month
Alok Kumar and Padum Singh are mutual person
- Agrani Homes Real Services Private LimitedActive 10 years 10 months
Alok Kumar and Padum Singh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 07 Sep 2016 | ₹0.50 M | Open |
How Many Employees Work at Agrani Pharmaceutical?
Unlock and access historical data on people associated with Agrani Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Agrani Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agrani Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
